Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000236495 | SCV000294249 | benign | Fanconi anemia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000503767 | SCV000594665 | benign | not specified | 2018-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000721015 | SCV000851899 | uncertain significance | History of neurodevelopmental disorder | 2013-03-16 | criteria provided, single submitter | clinical testing | Co-segregation data for this variant is currently unavailable.This variant has not been detected in conjunction with a pathogenic mutation to date.This variant was previously reported in the SNPDatabase as rs145110602. Based on data from the NHLBI Exome Sequencing Project (ESP), the A-allele has an overall frequency of approximately 0.25% (5/1997) total male alleles studied and but was not observed in the homozygous state out of 3381females studied. The A-allele was observed in 0.96% (5/522) African American male alleles but was absent out of 1475 European American male alleles studied. Based on data from the 1000 Genomes Project, the A-allele has an overall frequency of approximately 2/1048 (0.19%) and the highest frequency was in 2/48 (4.17%) African-American SW male chromosomes studied.This amino acid position is not conserved on species alignment.This alteration is predicted to be benign with a score of 0.002 (sensitivity: 0.99; specificity: 0.17)This alteration is predicted to be tolerated with a score of 0.390 (conservation: 2.57) |
KCCC/NGS Laboratory, |
RCV003316313 | SCV004017598 | benign | Fanconi anemia complementation group B | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003930015 | SCV004745426 | benign | FANCB-related condition | 2019-09-18 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000503767 | SCV001800787 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727653 | SCV001971103 | likely benign | not provided | no assertion criteria provided | clinical testing |